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Abstract The biological role of phosphatidylinositol (PI)-3 ki- 
nase was examined in osteoclast-like multinucleated cells (OCLs) 
formed in co-cultures of mouse osteoblastic eils and bone mar- 
row cells. The expression of PI-3 kinase in OCLs was confirmed 
by Western blot analysis. Wortmannin (WT), a specific inhibitor 
of PI-3 kinase, inhibited PI-3 kinase activity in OCLs both in 
vitro and in vivo. WT also inhibited pit-forming activity on dentine 
slices and disrupted a ringed structure of F-actin-containing dots 
(an actin ring) in OCLs in a dose-dependent manner. The inhib- 
itory profiles of WT for pit and actin ring formation were similar 
to that for PI-3 kinase activity in OCLs. Electron microscopic 
analysis revealed that OCLs treated with WT did not form ruffled 
borders. Instead, numerous electron lucent vacuoles of differing 
sizes were found throughout he cytoplasm. These results suggest 
that PI-3 kinase is important in osteoclastic bone resorption. 
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1. Introduction 
Phosphatidylinositol (PI)-3 kinase is one of the key enzymes 
activated in signaling pathways of growth factors [1,2]. It cata- 
lyzes phosphorylation of PI to P1-3-P, P1-4-P to PI-3,4-P2, and 
PI-4,5-P2 to PI-3,4,5-P3, respectively [3-5]. The roles of PI-3 
kinase have been studied extensively over the past few years. 
Involvement of PI-3 kinase in the action of $6 kinase [6], mem- 
brane ruffling [7,8], neurite formation [9], activation of protein 
kinase C (PKC) [10], actin polymerization [11,12], and trans- 
portation of proteins [13,14] has been suggested. However, it 
is still not clear how phosphatidylinositides produced by PI-3 
kinase work in these systems. 
Osteoclasts are primary bone-resorbing cells that play a crit- 
ical role in bone remodeling [15]. After adhesion to the bone 
surface, osteoclasts exhibit highly polarized cytoplasmic organ- 
izations such as ruffled borders and clear zones. The clear zone 
serves as the attachment site of osteoclasts to the bone surface 
through the specific adhesion machinery called podosomes 
which are composed of F-actin and other adhesion molecules. 
Recently, it has been shown that the signaling mediated by 
protein tyrosine kinases may play an important role in osteo- 
clastic bone resorption. Targeted disruption of the c-src gene 
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in mice induced osteopetrosis, a disease characterized by re- 
duced osteoclastic bone resorption [16]. Indeed, osteoclasts 
have been reported to express a high level of pp60 ..... [17,18]. 
Careful examination of osteoclasts in c-src-deficient mice re- 
vealed that they lacked ruffled borders [19]. PI-3 kinase is one 
of the enzymes that may be activated by the c-src tyrosine 
kinase [20,21]. In the present study, we examined whether PI-3 
kinase is involved in osteoclastic bone resorption, using wort- 
mannin (WT), a specific inhibitor of PI-3 kinase [22,23]. We 
report here that PI-3 kinase is involved in ruffled border forma- 
tion and actin rearrangement in osteoclasts. 
2. Materials and methods 
2.1. Materials' 
Polyclonal antibody against he 85 kDa subunit of PI-3 kinase (p85) 
was prepared as described previously [24]. Wortmannin, a gift from Dr. 
Y. Matsuda (Kyowa Hakko Kogyo Co., Japan), was dissolved in di- 
methyl sulfoxide at 1 mM, stored at -20 ° in the dark, and diluted 
with distilled water just before use. l~,25-Dihydroxyvitamin D 3
[l~,25(OH)2D3] was purchased from Wako Pure Chemical Co. (Osaka, 
Japan). [y-32p]ATP (111 TBq/mmol) was obtained from New England 
Nuclear Products (Boston, MA). 
2.2. Cells and cell cultures 
Mouse osteoclast-like multinucleated cells (OCLs) were prepared 
using ddY mice, as reported previously [25]. Primary osteoblastic cells 
obtained from newborn mouse calvaria and bone marrow cells ob- 
tained from tibiae of 7- to 9-week-old male mice were co-cultured in 
~-MEM containing 10% fetal bovine serum and 10 nM l~,25(OH)2D3 
on culture dishes precoated with 4 ml of 0.2% collagen gel matrix (Nitta 
Gelatin Co., Osaka, Japan). OCLs were formed within 6 days of cul- 
ture, and released from dishes by treating with 4 ml of 0.2% collagenase 
(Wako), and collected by centrifugation at250 × g for 5 min. The purity 
of OCLs in this fraction was about 5% (crude OCL preparation). For 
the PI-3 kinase assay, they were further purified with pronase according 
to the method escribed previously [26]. In the final preparation (puri- 
fied OCL preparation), more than 80% of the cells remaining on the 
dishes were TRAP-positive multinucleated and mononuclear cells, and 
more than 95% of the total protein was estimated to be derived from 
OCLs. 
2.3. Western blot analys& 
Osteoblastic cells, crude OCL preparations, and purified OCL prep- 
arations were lysed with RIPA buffer (50 mM Tris-HC1, pH 7.8, 1% 
(v/v) Nonidet P-40, 20 mM EDTA, 0.1% sodium dodecyl sulfate, 0.1% 
sodium deoxycholate, 2 mM sodium orthovanadate, 10mM sodium 
fluoride and aprotinin at 10 ,ug/ml). RIPA extracts were prepared by 
centrifugation at 12,000×g for 15 min. Samples containing equal 
amounts of protein were suspended in Laemmli sample buffer, and 
electrophoresed on SDS-polyacrylamide g ls. After electrophoresis, 
proteins were transferred to Immobilon-P (Millipore Co., Bedford, 
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MA). Immunostaining with anti-p85 antibody was performed using 
ECL Western blotting detection reagents (Amersham International 
plc., Amersham Place, UK). 
2.4. Assay for PI-3 kinase 
PI-3 kinase was assayed as described before [21]. Briefly, PI-3 kinase 
was immunoprecipitated from purified OCL preparations with polyclo- 
nal anti-p85 antibody and washed thoroughly. PI-3 kinase activity was 
measured by incubating immunoprecipitates with PI and [7-32p]ATP. 
Phosphorylated products of PI were separated by thin layer chromato- 
graphy. 
2.5. Assay for pit-forming activity of OCLs on dentine slices 
To assess bone-resorbing activity of OCLs, pit-forming activity of 
OCLs on dentine slices was determined by the method previously re- 
ported [27]. Crude OCL preparations were placed on dentine slices and 
incubated for 48 h with or without WT. Since the activity of WT 
declined within 5 h [9], fresh WT was supplied every 5 h. At the end 
of the culture period, the dentine slices were cleaned by ultrasonication 
to remove adherent cells. The slices were then stained with Mayer's 
hematoxylin solution. To quantitate pit-forming activity of OCLs, the 
areas of resorption lacunae were measured with an image analysis 
system (LA-525; PIAS Co., Tokyo). The results are expressed as the 
percentage of resorbed area with respect to the whole surface area of 
a dentine slice. 
2.6. Podosome formation in OCLs 
Podosomes formed in OCLs were visualized by F-actin staining with 
rhodamine-conjugated phalloidin as described before [26]. Crude OCL 
preparations placed on culture dishes for 3 h were fixed with 3.7% 
formaldehyde in phosphate buffered saline (PBS) for 10 min, and per- 
meated by 0.1% Triton X-100 in PBS for 5 min. To identify OCLs, cells 
were stained for TRAP. After washing with PBS, F-actin was stained 
with 0.3 pM rhodamine-conjugated phalloidin. Distribution of F-actin 
was detected under a fluorescent microscope (Olympus BX-FLA, 
Osaka). 
2.7. Preparation of ultrathin sections 
Crude OCL preparations were cultured on dentine slices for 3 h and 
then treated with or without 100 nM WT for 60 min, and fixed with 
2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.3). They 
were postfixed with 1.5% potassium ferrocyanide-reduced 1% osmium 
tetroxide, block-stained with 1% uranyl acetate, dehydrated with a 
graded ethanol series, and embedded in Quetol 812 (Nisshin EM, 
Tokyo). Ultrathin sections were stained with uranyl acetate and lead 
citrate, and examined in a Hitachi HU-12A electron microscope at 
75 kV. 
3. Results and discussion 
Fig. la shows a Western blot analysis of PI-3 kinase in lysates 
from mouse osteoblastic cells (lane 1), crude OCL preparations 
(lane 2), and purified OCL preparations (lane 3). PI-3 kinase 
was detected in the three preparations. These results demon- 
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Fig. 1. Effects of WT on PI-3 kinase activity in OCLs in vitro and in vivo. (a) Western blotting of PI-3 kinase. Expression of PI-3 kinase in lysates 
from mouse osteoblastic cells (lane 1), crude OCL preparations (lane 2), and purified OCL preparations (lane 3) was analyzed by Western blotting. 
The numbers on the right indicate the positions of molecular weight markers. (b) Examination of PI-3 kinase activity in anti-p85 immunoprecipitates 
prepared from purified OCL preparations. After treatment of the immunoprecipitates with WT for 10 min, PI-3 kinase activity was analyzed. 
(c) Effect of WT on PI-3 kinase activity in vivo. After purified OCL preparations were pretreated with WT for 60 rain, PI-3 kinase was immunoprecip- 
itated with anti-p85 antibody and the activity in the immunoprecipitates was analyzed. Positions of the origin and PI-3-P spots are shown on the 
right in panels b and c. 
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Fig. 2. Effect of WT on pit-forming activity of OCLs on dentine slices. 
Crude OCL preparations were cultured on dentine slices with graded 
concentrations of WT. After culture for 48 h, resorption pits formed 
on dentine slices were stained with Mayer's hematoxylin and quanti- 
tated using an image analysis ystem. (a) Pits on dentine slices in the 
control culture. (b) Pits on dentine slices in cultures treated with 100 
nM WT. (c) Effect of WT on pit-forming activity of OCLs 
(means + S.D.; n = 5). *Significantly different from the group treated 
without WT, P<0.01. Bars = 200 pm. 
strate that not only osteoblastic cells but also OCLs express 
PI-3 kinase. To determine the effect of WT on PI-3 kinase 
activity in OCLs, PI-3 kinase was immunoprecipitated from 
purified OCL preparations with anti-p85 antibody and the ac- 
tivity was determined in the presence or absence of WT. The 
immunoprecipitates exhibited PI-3 kinase activity, which was 
inhibited dose-dependently by WT (Fig. lb). The activity of 
PI-3 kinase was completely inhibited by WT at 100 nM. The 
effect of WT on PI-3 kinase in intact OCLs was examined as 
well. Pretreatment of OCLs with WT for 60 min inhibited PI-3 
kinase activity in a dose-dependent manner (Fig. lc). PI-3 ki- 
nase activity was almost completely inhibited by 100 nM WT. 
OCLs placed on dentine slices formed resorption pits within 
48 h (Fig. 2a). When crude OCL preparations were treated with 
WT, pit-forming activity of OCLs was inhibited dose-depen- 
dently (Fig. 2c). The concentration of WT for the complete 
inhibition of pit-forming activity was 100 nM. 
When OCLs were placed on culture dishes, more than 80% 
of the OCLs spread out and formed ringed structures of F-actin 
(actin rings) within 3 h (Fig. 3c and e). When WT was added 
at 100 nM, actin rings in OCLs disappeared almost completely 
within 60 min, resulting in the distribution of the actin-contain- 
ing dots throughout the cytoplasm (Fig. 3d). WT, however, did 
not appear to cause distinct structural changes in the stress 
fibers of F-actin in osteoblastic cells contaminating the crude 
OCL preparation (Fig. 3d, arrows). The inhibitory profiles of 
WT for the pit-forming activity by OCLs and for the actin ring 
formation in OCLs were similar to that for PI-3 kinase activity 
in vivo (Figs. lc, 2c and 3e). It may be that WT might be 
inhibiting other enzymes uch as the myosin light chain kinase. 
However, it has been well established that a much higher con- 
centration of WT is required to inhibit these enzymes [22,28]. 
Moreover, the effect of WT on PI-3 kinase activity in OCLs 
exactly corresponded with that observed in other types of cells 
reported in previous tudies [22,23]. Although there is no direct 
evidence that myosin light chain kinase is not inhibited by 100 
nM WT, it is likely that PI-3 kinase is involved in both osteo- 
clastic bone resorption and actin rearrangement i  podosome 
formation. 
At an ultrastructural level, OCLs treated with 100 nM WT 
did not form ruffled borders (Fig. 4). Instead, many pale vacu- 
oles of differing sizes were distributed throughout he cyto- 
plasm (Fig. 4a). Although fusion of adjacent vacuoles fre- 
quently occurred (Fig. 4 arrow heads), these vacuoles never 
fused with apical membranes facing the dentine surface (Fig. 
4b). Control OCLs formed ruffled borders on dentine slices in 
the absence of WT (data not shown). These results uggest that 
PI-3 kinase is involved in ruffled border formation in osteo- 
clasts as well. 
It has been shown that pp60 ....... is required for the ruffled 
border formation of osteoclasts [16-19]. Since it is suggested 
that PI-3 kinase is activated by pp60 ....... [20,21], it is natural to 
speculate that PI-3 kinase is involved in osteoclastic bone re- 
sorption. The present study suggests that PI-3 kinase is in- 
volved in osteoclastic bone resorption through the ruffled 
border formation. PI-3 kinase may be involved in actin rear- 
rangement and cytoskeleton formation [8,11,12]. In our exper- 
iments, the inhibitory profiles of WT for actin ring formation 
and for PI-3 kinase activity in vivo were very similar. This 
suggests that PI-3 kinase plays a regulatory role in the rear- 
rangement of actin cytoskeletons in osteoclasts as well. In con- 
trast, stress fibers in osteoblastic cells were not affected by WT 
(Fig. 3d, arrows). The reason why the actin rearrangement was 
abolished by WT in one cell type but not in the other is not clear 
at present. Different cytoskeletal structures may be present in 
OCLs and osteoblastic cells. The actin ring formation appears 
to be a prerequisite for the ruffled border formation in osteo- 
clasts, because the disruption of actin rings by calcitonin, her- 
bimycin A and bisphosphonates prevented ruffled border for- 
mation and inhibited osteoclastic bone resorption (unpublished 
results). There could be a direct or indirect link between the 
actin ring formation and the ruffled border formation. Further 
studies are required to substantiate his hypothesis. 
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Fig. 3. Disruption of F-actin rings in OCLs by WT. Crude OCL preparations were placed on culture dishes. After culture for 3 h, they were treated 
with (b and d) or without (a and c) 100 nM WT for 60 min. Light micrographs (a and b) and fluorescent micrographs (c and d) were prepared of 
OCLs stained for TRAP followed by rhodamine-conjugated phalloidin staining. Arrows in panel d indicate stress fibers in osteoblastic cells. (e) Effect 
of WT on F-actin rings in OCLs (means + S.D.; n = 4). More than 150 OCLs were evaluated in each group. *Significantly different from the group 
treated without WT, P<0.01. Bars = 40 ,um. 
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Fig. 4. Morphological changes in OCLs treated with WT. (a) Electron micrograph of an OCL placed on a dentine slice in the presence of 100 nM 
WT. (b) A high-power view of a portion of the apical membrane in another OCL on a dentine slice. Arrow heads indicate fusion of adjacent vacuoles. 
Bars in a -- 5/ lm; in b = 1/lm. 
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